Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities
Net loss	$ (14,080,454)	$ (8,236,481)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	1,767	1,325
Amortization	424,813	141,604
Impairment expense	0	5,402,729
Stock-based compensation - employees	7,777,900
Stock-based compensation - non-employees	1,587,200
Non-cash interest expense	1,972,836	1,344,559
Non-cash interest expense – related parties	336,139	256,612
Deferred lease expense	54,302
Security deposit loss		7,265
Foreign exchange loss	89,125	47,539
Changes in operating assets and liabilities which provided (used) cash
Other receivable	(222,562)
Accounts payable	(75,147)	(9,057)
Accounts payable – related parties	(51,008)	(12,006)
Accrued expenses	8,227	352,069
Net cash used in operating activities	(2,176,862)	(703,842)
Cash flows from investing activities
Advance on business acquisition	(350,000)	(425,328)
Leasehold improvements in progress	(160,724)
Purchase of light patent		(7,841)
Net cash used in investing activities	(510,724)	(433,169)
Cash flows from financing activities
Issuance of loans payable – related parties		28,964
Repayment of loans payable – related parties	(10,000)
Issuance of convertible notes	2,220,193	569,412
Issuance of convertible notes - related parties	500,000	598,000
Preferred stock buy-back	(10)
Net cash provided by financing activities	2,710,183	1,196,376
Net increase in cash and cash equivalents	22,597	59,365
Cash and cash equivalents, beginning of year	62,381	3,016
Cash and cash equivalents, end of year	84,978	62,381
Supplemental cash flows disclosures
Cash paid for interest	68,127
Non-cash transactions - investing and financing activities
Conversion of rents due to convertible loan	271,512
Accrued expense converted to convertible loans	552,935
Acquisition of equipment in exchange for loan payable from R&D Labs, a related party	300,000
Sale of equipment in exchange for note receivable - related party	44,859
Distribution	255,141
Loans payable- related parties reclassified to convertible notes - related parties		1,357,484
Accrued interest reclassified to convertible notes payable - related parties		254,829
Accrued expense reclassified to convertible notes payable		105,206
Construction in progress exchanged for patent		1,096,816
Land exchanged for patent		1,064,651
Liability related to patent acquisition		5,000,000
Loans payable exchanged for patent		194,825
Patent acquired with above consideration		$ 7,356,292